Reversible downregulation of the hypothalamic-pituitary-gonadal axis in stallions with a novel GnRH antagonist

G. M. Davolli, B. A. Ball, A. Esteller-Vico, A. N.J. Claes, I. F. Canisso, C. E. Fedorka, E. M. Woodward, M. H.T. Troedsson, E. L. Squires

Research output: Contribution to journalArticle

Abstract

The GnRH antagonist, acyline, has not yet been investigated in the stallion. Our study aimed to: (1) evaluate the downregulation of the stallion hypothalamic-pituitary-gonadal axis by acyline through assessment of seminal parameters, testicular volume, and sexual behavior; (2) assess hormonal response of acyline-treated stallions to GnRH stimulation; and (3) verify reversibility after treatment. Stallions were assessed pretreatment and subsequently treated (every five days) for 50 days: acyline (n = 4; 330 μg/kg acyline) or control (n = 4, vehicle). The stallions were then monitored for 62 days after the last day of treatment. Treatment-induced declines (P < 0.05) in FSH, LH, testosterone, and estrone sulfate. Gonadotropins and testosterone returned to control values within 9 days, and estrone sulfate by 14 days, after discontinuation of treatment. Acyline-treated stallions failed to respond with a rise in FSH, LH, and testosterone after exogenous GnRH stimulation (gonadorelin) at Day 46 of treatment compared to pretreatment stimulation and control stallions. Decreases (P < 0.05) were observed in total sperm numbers and motility (week 2) in acyline-treated stallions, as well as total seminal plasma protein (week 2) and testicular volume (week 5). Over the course of the study, the time to erection, time to ejaculation, and number of mounts increased (P < 0.0001) across both groups of stallions; however, there was no effect of treatment or treatment by time interactions on these parameters. Testicular volume, and most seminal parameters regained normal levels within 62 days after treatment ended; on follow-up, sperm output of acyline-treated stallions was regained within 7 months after the end of experiment. In conclusion, acyline reversibly suppresses the stallion hypothalamic-pituitary-gonadal axis.

Original languageEnglish (US)
Pages (from-to)2272-2280
Number of pages9
JournalTheriogenology
Volume86
Issue number9
DOIs
StatePublished - Dec 1 2016

Keywords

  • GnRH antagonist
  • Hypothalamic-pituitary-gonadal axis
  • Sexual behavior
  • Stallion
  • Testosterone suppression

ASJC Scopus subject areas

  • Small Animals
  • Food Animals
  • Animal Science and Zoology
  • Equine

Fingerprint Dive into the research topics of 'Reversible downregulation of the hypothalamic-pituitary-gonadal axis in stallions with a novel GnRH antagonist'. Together they form a unique fingerprint.

  • Cite this

    Davolli, G. M., Ball, B. A., Esteller-Vico, A., Claes, A. N. J., Canisso, I. F., Fedorka, C. E., Woodward, E. M., Troedsson, M. H. T., & Squires, E. L. (2016). Reversible downregulation of the hypothalamic-pituitary-gonadal axis in stallions with a novel GnRH antagonist. Theriogenology, 86(9), 2272-2280. https://doi.org/10.1016/j.theriogenology.2016.07.021